This study was used to study the diagnostic value of 68Ga-FAPI, a novel fibroblast activating inhibitor, in metastatic adenoid cystic carcinoma（ACC）
68Ga-FAPI is a positron labeled inhibitor of fibroblast activating protein, which has been widely used in malignant tumor imaging in recent years. Adenoid cystic carcinoma (ACC) is a rare epithelial malignant tumor, which usually originates from salivary glands. Its typical characteristics are long clinical course and high rate of distant metastasis. The purpose of this study was to investigate the clinical value of 68Ga Fapi pet/ct in metastatic adenoid cystic carcinoma.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
30
68Ga-FAPI were injected into the patients before the PET/CT scans
Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College
Beijing, China
RECRUITINGStandardized uptake value of 68Ga-FAPI in ACC
The maximum and mean standard uptake values (SUVmax and SUVmean) were measured in the background of lesion, liver, muscle and mediastinal blood pool, respectively.
Time frame: 1 year
lesions detected by 68Ga-FAPI PET/CT
The number of target lesions in each organ system was calculated by 68Ga-FAPI PET/CT
Time frame: 1 year
Zhaohui Zhu
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.